Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture

Ramchandani, Neesha; Arya, Sandeep; Ten, Svetlana; Bhandari, Sonal

doi:10.1177/193229681100500407

Cited by 77 publications

(92 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Others have listed similar hassles (irritations and annoying issues) associated with current-generation CGM technologies (14). Several participants in our survey reported that they understood and allowed for the limitations of CGM: many commented that they liked CGM even if it was perceived to be inaccuratedsensor accuracy was not the primary factor in CGM satisfaction.…”

Section: Discussionmentioning

confidence: 90%

“…Although patient satisfaction and quality of life with CGM have been explored through questionnaire-based studies (9)(10)(11)(12)(13)(14), much less is known about patients' and caregivers' lived experiences of realtime CGM, when described in their own words ("narratives"). Such information informs the debate on achieving quality in healthcare by adding patient-centered data on perceived treatment satisfaction, quality of life, well-being, adverse effects, problems, complications, and ease-of-use to the objective evidence of clinical effectiveness.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives

Holloway²,

2014

View full text Add to dashboard Cite

OBJECTIVEThis study analyzed narratives about experiences of real-time continuous glucose monitoring (CGM) in people with type 1 diabetes. RESEARCH DESIGN AND METHODSPeople with type 1 diabetes using CGM and caregivers completed an online survey. Questions included duration of CGM, frequency of sensor wear, funding, and a free narrative about experiences or views about CGM. We used qualitative framework analysis to analyze 100 responses; 50% of participants were aged ‡18 years. RESULTSMost participants (87%) used CGM with insulin pump therapy, 71% used sensors ‡75% of the time, and 66% received funding for CGM from the National Health Service. Four themes were identified: 1) metabolic control, 2) living with CGM (work and school, sleep, exercise, nutrition, frequency of self-monitoring of blood glucose [SMBG]), 3) psychological issues and patient/caregiver attitudes, and 4) barriers to CGM use (technical issues, financial issues, attitudes of healthcare professionals toward CGM). Despite some hassles, experiences were overwhelmingly positive, with improved glycemic control, diet and exercise management, quality of life, and physical and psychological well-being, as well as reduced frequency of SMBG. Technical problems included sensor inaccuracy and unreliability, and "alarm fatigue." The advantages of CGM used with an insulin pump with automatic suspension of insulin delivery during hypoglycemia were recorded by several participants, noting reduced hypoglycemia frequency and fear of nocturnal hypoglycemia. CONCLUSIONSPatient and caregiver narratives indicate that CGM is a valuable addition to diabetes care for many with type 1 diabetes.

show abstract

Section: Discussionmentioning

confidence: 90%

mentioning

confidence: 99%

Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives

Holloway²,

2014

View full text Add to dashboard Cite

show abstract

“…5,18,19 The sensor investigated in this study also showed its poorest performance in the low glycemic range. However, compared with currently available CGM systems, the sensor's performance in this range was remarkably better.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring

Zschornack¹,

Schmid²,

Pleus³

et al. 2013

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

“…Учитывая необходимость интенсивного обучения, а также зависимость эффекта от непосредственных действий пациентов, безусловно, не все люди с СД смогут использовать НМГ-РВ в повседневной жиз-ни. Некоторые из пациентов просто не захотят это-го; подобные приборы активно влияют на жизнеде-ятельность, что может быть воспринято как «вмеша-тельство в личную жизнь» [49,50].…”

Section: непрерывное мониторирование в режиме «реального времени»unclassified

Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT

Shestakova

Владимировна²,

Mayorov

et al. 2015

Probl Endokrinol (Mosk)

View full text Add to dashboard Cite

Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) and continuous glucose monitoring (CGM) are high-tech treatment and diagnostic tools for diabetes patients management which are actively used worldwide. CSII initiation and pump-users supervision became a part of routine clinical practice in Russia along with the CGM. Present project of clinical guidelines is based on international and domestic experience in CSII and CGM for diabetes treatment. Guidelines should ensure uniformity of CGM and CSII usage in Russia by health care professionals and diabetes patients and provide them an international experience to guarantee height performance of the technology. This article contains a preliminary version of the guidelines (draft) prepared for further expert’s discussion and review. The final version of the clinical guidelines will be sent to the Ministry of Health of the Russian Federation for approval.

show abstract

Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture

Cited by 77 publications

References 16 publications

Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives

Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives

Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring

Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT

Contact Info

Product

Resources

About